Oxocrebanine inhibits the proliferation of hepatocellular carcinoma cells by promoting apoptosis and autophagy

Figure 3 Protein expression levels of cleaved caspase3 and PARP in Hep3B2. 1-7 cells. A: Western blot analysis of cleaved caspase3 (c-caspase3) protein level in Hep3B2.1-7 cells after treatment with oxocrebanine. VP16 (32.54 μmol/L) was used as a control; B: Western blot analysis data indicated that the expression of c-caspase3 was upregulated with oxocrebanine treatments; C: Level of PARP1 in Hep3B2.1-7 cells after treatment with oxocrebanine. VP16 (32.54 μmol/L) was used as a control; D: Western blot analysis data showed that the expression of PARP1 was downregulated by oxocrebanine treatments. Data are shown as the mean ± SD. ^aP < 0.01 vs control (n = 3).